Paul Grayson is the founder of Tentarix Biotherapeutics. Tentarix Biotherapeutics has raised $132M in total funding. Latest round: Series B.
Paul Grayson is the President and CEO of Tentarix Biotherapeutics, a biotechnology company focused on leveraging its proprietary Tentacles™ platform to discover and develop multi-functional, conditional protein therapeutics. He has also been appointed as the CEO of Radionetics Oncology, a clinical-stage radiopharmaceutical company.
Full founder directory · Investor directory · Company funding database · Fundraising library
The Startup Fundraising Platform
Raise funds for your startup
Find the right investors and get real replies — instantly, powered by AI.
Takes 30 seconds · No credit card · Cancel anytime
Slide-by-slide guide